Dec 2011, Issue 7
News and analysis for pharmaceutical, biotechnology, medical device, diagnostic and healthcare companies
The issue opens with a special report on PwC's recent acquisition of PRTM consulting and an outline of the opportunities our new combined team can bring to clients within the Asia Pacific region.
In our compliance section we have included further information on the newly issued Good Manufacturing Practice 2010 and its impact on domestic pharmaceutical companies in the development process of living up to western standards. While New Good Supply Practice is also in draft stage.
In pricing section, the National Development and Reform Commission has demonstrated its determination in price cut by bringing down prices of drugs with high average daily costs and to narrow the gap between off-patent originator drugs of multinational corporations and local products.
And read about the latest news in the tax section covering Indirect Tax Reform in China - VAT Reform Pilot Program officially announced. Pharmaceutical companies doing business in Shanghai and other parts of China should assess its readiness for a smooth transition.
Other issues of Asia Pacific Pharmaceutical NewsletterVisit our
Pharmaceuticals Library.
